Retroperitoneal fibrosis and ß-blocking agents: Is there an association?

Kharagjitsing, Hardjit; van Eekeren, Rike; van Puijenbroek, Eugène P; van Gelder, Teun; van Bommel, Eric F H

Kharagjitsing, Hardjit; van Eekeren, Rike; van Puijenbroek, Eugène P; van Gelder, Teun; van Bommel, Eric F H.

Afiliación

Kharagjitsing H; Department of Internal medicine, Dutch national center of expertise for retroperitoneal fibrosis, Albert Schweitzer hospital, Dordrecht, The Netherlands.
van Eekeren R; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
van Puijenbroek EP; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
van Gelder T; Department of Pharmacotherapy, epidemiology and economics, Groningen Research Institute of Pharmacy, University of Groningen, The Netherlands.
van Bommel EFH; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.

Br J Clin Pharmacol ; 87(7): 2891-2901, 2021 07.

Article en En | MEDLINE | ID: mdl-33326117

Asunto(s)

Fibrosis Retroperitoneal; Teorema de Bayes; Bases de Datos Factuales; Humanos; Farmacovigilancia; Fibrosis Retroperitoneal/inducido químicamente; Fibrosis Retroperitoneal/diagnóstico; Fibrosis Retroperitoneal/epidemiología

Palabras clave

case reports; disproportionality analysis|; retroperitoneal fibrosis; spontaneous reporting; ß-blocking agents

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis Retroperitoneal Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google